Companies: 10,795·Total market cap: $144.5T
Lunai Bioworks Inc.

Lunai Bioworks Inc.

LNAINASDAQHealthcare● Active
$2.37
$-0.08(-3.27%)
Market Cap$10745319
P/E Ratio—
52W High$33.52
52W Low$1.208
EarningsFinancialsRevenue

Lunai Bioworks Inc. (LNAI) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LNAI · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026
EPS Actual
-$0.80
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
LNAI reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q2 FY2026
May 15, 2026
EPS Actual
-$0.80
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2026
Feb 17, 2026
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 14, 2025
EPS Actual
$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 15, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for LNAI.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q2 FY2026-6.79%
Report Date
May 15, 2026
EPS Beat/Miss
—
Price Before
$2.21
Price After
$2.06
Q1 FY2026-9.18%
Report Date
Feb 17, 2026
EPS Beat/Miss
—
Price Before
$5.88
Price After
$5.34
Q4 FY2025+2.91%
Report Date
Nov 14, 2025
EPS Beat/Miss
—
Price Before
$8.24
Price After
$8.48
Q2 FY2025—
Report Date
May 15, 2025
EPS Beat/Miss
—
Price Before
—
Price After
$18.24
Beat Rate0 / 4 quarters
Largest Move-9.18% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: LNAI ends December

Lunai Bioworks Inc. (LNAI) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-0.80 (in line with the analyst consensus of —). The next LNAI earnings date is expected around September 1, 2026.

Each quarter, investors track LNAI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LNAI revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LNAI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

LNAI earnings · 4 questions

Lunai Bioworks Inc.'s next earnings report is expected around September 1, 2026. LNAI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LNAI historically reports after market close (AMC).

LNAI earnings datewhen is LNAI earningsLNAI next earnings datewhen does LNAI report earningsLNAI earnings calendar

▸ Source: FMP · Lunai Bioworks Inc. SEC filings · US GAAP · Lunai Bioworks Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026